Inhibition of interleukin-17 in patients with oligoarticular psoriatic arthritis
<p><strong><i>Introduction:</strong></i> This study evaluated the efficacy of the interleukin-17A inhibitor secukinumab in patients with oligoarticular psoriatic arthritis (PsA).</p> <p><strong><i>Methods:</strong></i> A total of 84...
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Journal article |
| Kieli: | English |
| Julkaistu: |
Springer
2023
|